RxDoctor Payments Data

Kunda Biswas, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Bethesda, MDNPI 1902992985

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $517 and has fallen 84.2% since, to $81 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in MD, where the typical reported total is $3,226.

$1,273in general payments, 2019–2025

Across 41 payments — averaging $31.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shockwave Medical, Inc$259
  • Boston Scientific$223
  • Philips North America LLC$93
  • Angiodynamics, Inc.$92
  • Medtronic$83
  • Bard Peripheral Vascular, Inc.$74
  • plus $449 from 14 others

What the payments were for

  • Food & beverage$1,273100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,273 in reported general payments places this provider in the 35th percentile of 65 thoracic surgery (cardiothoracic vascular surgery) providers in Maryland.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Maryland

Medicare billing

Part B allowed, 2024
$528,293
Medicare patients
244
Services billed
960

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban17$15,226
EliquisApixaban12$11,716
ClopidogrelClopidogrel Bisulfate93$1,105
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen21$109

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →